Immune Therapeutics, Inc. 4
4 · Immune Therapeutics, Inc. · Filed Apr 13, 2016
Insider Transaction Report
Form 4
Selsky Clifford
Director
Transactions
- Other
COMMON STOCK
2016-04-08+250,000→ 250,000 total(indirect: By LLC)
Footnotes (2)
- [F1]The shares were issued pursuant to a compensation agreement as a director of the company. The cost-basis is the market price on the day of issuance of $0.14
- [F2]The shares were issued directly to Selsky Consulting, LLC which is owned 100% by the reporting person.